These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7243691)

  • 1. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic investigations of Craviten. II. Dose-dependent elimination kinetics in rats following rapid intravenous injection.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):933-9. PubMed ID: 7243690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic investigations of Craviten. IV. First-pass metabolism in rats.
    Danek A; Witek J
    Pol J Pharmacol Pharm; 1980; 32(6):949-53. PubMed ID: 7243692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic investigations of Craviten. I. Spectrofluorometric determination of the drug in biological material.
    Witek J; Danek A
    Pol J Pharmacol Pharm; 1980; 32(6):927-32. PubMed ID: 7243689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacokinetics of falirytmin given orally to humans].
    Weiss M; Sziegoleit W; Henschke E; von Keyserlingk G; Hafemeister G; Pönicke K; Förster W
    Pharmazie; 1980 Feb; 35(2):123. PubMed ID: 7384184
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic studies of ethylenediamine derivatives: absorption, tissue distribution and elimination of IF-ROM-203-14C compound.
    Nowicka A; Szukalski B; Prussak T; Jahn W
    Mater Med Pol; 1977; 9(3):239-43. PubMed ID: 926839
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of Craviten decomposition in aqueous solutions.
    Kubiak Z; Kuncewicz B; Zurańska M
    Pol J Pharmacol Pharm; 1980; 32(6):917-25. PubMed ID: 7243688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of some ethylenediamine derivatives with antiarrhythmic properties. I. Absorption, distribution in tissues and excretion of 14-C labelled N, N'-bis-[3-(p-methoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dimethanesulphonate (MK-142) in rats.
    Nowicka A; Prussak T; Szukalski B
    Pol J Pharmacol Pharm; 1975; 27(2):113-20. PubMed ID: 168561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic properties of rithmidazole upon single intravenous introduction].
    Spasov AA; Stepanov AV; Smirnova LA; Petrov VI; Shabasheva IG
    Eksp Klin Farmakol; 2002; 65(3):57-61. PubMed ID: 12227100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent pharmacokinetics of tocainide in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):231-4. PubMed ID: 6778990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC determination of safflor yellow A and three active isoflavones from TCM Naodesheng in rat plasma and tissues and its application to pharmacokinetic studies.
    Yu Z; Gao X; Zhao Y; Bi K
    Biomed Chromatogr; 2007 Jun; 21(6):577-84. PubMed ID: 17385809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tissue distribution and excretion of bromotetrandrine in rats].
    Xiao SH; Wei GL; Lu R; Liu CX; Wang FP
    Yao Xue Xue Bao; 2005 May; 40(5):453-6. PubMed ID: 16220792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saturable uptake of a recombinant human granulocyte colony-stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in vivo.
    Kuwabara T; Uchimura T; Takai K; Kobayashi H; Kobayashi S; Sugiyama Y
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1114-22. PubMed ID: 7540687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of chlorcyclizine and meclizine to rats: accumulation of a metabolite formed by piperazine ring cleavage.
    Gaertner HJ; Breyer U; Liomin G
    J Pharmacol Exp Ther; 1973 May; 185(2):195-201. PubMed ID: 4145042
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of selol, a new agent containing selenium, in rats.
    Jastrzebski Z; Czyzewska-Szafran H; Remiszewska M; Fijalek Z; Fitak BA; Suchocki P
    Drugs Exp Clin Res; 1997; 23(1):7-11. PubMed ID: 9093817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age-related characteristics of potassium glutamate pharmacokinetics].
    Zapadniuk VI; Kuprash LP; Zaika MU; Oranskaia SA
    Farmakol Toksikol; 1984; 47(2):58-61. PubMed ID: 6143684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats.
    Dinis-Oliveira RJ; Duarte JA; Remião F; Sánchez-Navarro A; Bastos ML; Carvalho F
    Toxicology; 2006 Oct; 227(1-2):73-85. PubMed ID: 16956706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of radiocolloid distribution following administration by portal vein and peripheral vein injections.
    Ackerman NB
    J Nucl Med; 1967 May; 8(5):349. PubMed ID: 6032643
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue distribution of chloroquine in the rat.
    Varga F
    Acta Physiol Acad Sci Hung; 1968; 34(4):319-25. PubMed ID: 5712947
    [No Abstract]   [Full Text] [Related]  

  • 20. Central action of Craviten (M-71).
    Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
    Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.